1. Introduction
===============

The first SARS case was reported in China\'s Guangdong Province in November of 2002. The total number of cases recorded in China climbed to over 5200 with about 5--10% mortality by the end of 2003. It has been confirmed that SARS is caused by a new coronavirus, but its epidemiology is little known ([@bib9], [@bib17], [@bib24]). Consequently, modelers are struggling to estimate the severity of the SARS epidemic, the effectiveness of control measures and to provide earlier warning of possible SARS outbreaks ([@bib26]). Mathematical models have been widely used to calculate and describe the dynamic evolution of epidemic threshold values and severity ([@bib2], [@bib1]). The most widely used is the Kermarck-McKendrik model, also called the SIR model ([@bib7]), which is based on a system of three populations: susceptible, infectious and removals. Various epidemic models have been developed from the classic SIR model for different purposes, or with different assumptions, e.g. the SIRS model ([@bib20]), SEIR model ([@bib14]), two-level or two-stage SIR model ([@bib3]), SIR models considering immunity ([@bib11]), intermediate class ([@bib18]), non-linearity of infection ([@bib19], [@bib28], [@bib25]), etc. In classic SIR models, the effective reproductive number, *R*, is the threshold parameter of epidemic diseases: if *R*  \< 1, the disease will eventually disappear, but *R*  \> 1 implies that the disease will persist ([@bib13], [@bib27], [@bib8]). Therefore, knowledge of *R* is extremely valuable for developing epidemic management strategies as it gives some indication of the effort required to reach specific goals ([@bib28], [@bib25]). Recently, two studies reported the transmission epidemic of SARS in Singapore and Hong Kong ([@bib9], [@bib17], [@bib24]). Both estimated the basic reproduction number *R* ~0~ is order of 2--4. Both teams make use of mathematical models based on a system of four subpopulations: susceptible, exposed, infectious, and recovered (immune) individual, also called a SEIR model.

2. The discrete models
======================

We developed a discrete SARS model based on the following groups: susceptible individuals, *N* ~1~(*t*); non-hospitalized SARS persons, *N* ~2~(*t*); hospitalized patients, *N* ~3~(*t*); cured hospital patients, *N* ~4~(*t*); and those who have died due to SARS infection, *N* ~5~(*t*); ([Fig. 1](#fig1){ref-type="fig"}a). The infectious period of non-hospitalized patients, *T* ~1~(*t*), is defined as the time non-hospitalized SARS persons from being infectious to being removed to hospitals. We assume that non-hospitalized SARS persons are infectious at the rate *P* ~1~(*t*). Infected people with symptoms, once detected, are removed immediately to hospital for isolation and treatment. These infected patients further infect doctors, nurses and other front-line hospital staff at the rate *P* ~2~(*t*) during the treatment period *T* ~2~(*t*) in hospitals. Non-hospitalized SARS individuals are composed of two sub-groups: front-line hospital staff (doctors, nurses, etc.), *N* ~2d~(*t*), and the general public, *N* ~2n~(*t*). Non-hospitalized SARS people, *N* ~2~(*t*), infect the general public, *N* ~2n~(*t*), at the rate *P* ~1~(*t*), while hospitalized SARS patients, *N* ~3~(*t*), infect front-line hospital staff, *N* ~2d~(*t*), at the rate *P* ~2~(*t*). The transfer rates from *N* ~2~(*t*) to *N* ~3~(*t*) is determined by *T* ~1~(*t*), and the transfer rate from *N* ~3~(*t*) to *N* ~4~(*t*) or *N* ~5~(*t*) are determined by the proportion of cured patients, *P* ~3~(*t*), and *T* ~2~(*t*). The proportion of mortality due to SARS infection is 1 −  *P* ~3~(*t*). This model is especially designed for estimating the basic and effective reproductive number of the SARS virus from the data that has been released daily by the Chinese Ministry of Health (CMH) since April 21, 2003.Fig. 1(a) Diagramatic representation of the SARS model. See text for symbol definitions; (b) the outbreak pattern and the effective reproductive number of the SARS model. When *R* \< 1 (○), the outbreak curve is a power curve (*P*~1~ = 0.0062, *P*~2~ = 0.1473, *T*~1~ = 4.5, *T*~2~ = 14); when *R* \> 1(□), the outbreak curve is exponential (*P*~1~ = 0.0378, *P*~2~ = 0.2144, *T*~1~ = 4.5, *T*~2~ = 14); when *R* = 1(▴), the outbreak curve is linear (*P*~1~ = 0.01404, *P*~2~ = 0.1785, *T*~1~ = 4.5, *T*~2~ = 14). The initial values of total cumulative cases, cumulative mortality, cumulative recovered patients and cumulative cases are 3106, 139, 1306 and 653, respectively.

We assume that the immigration and emigration rates of infected individuals are the same. Clinical observations indicate that cured SARS patients are unlikely to be infectious again ([@bib29]). We will ignore the effect of natural birth and mortality rates because we are only interested in the dynamics of the SARS epidemic over a period of short time (e.g. a few weeks or months). The dynamic model is described as below:$$N_{1}(t + 1) = N_{1}(t) - P_{1}(t) \cdot N_{2}(t) - P_{2}(t) \cdot N_{3}(t)$$ $$N_{2}(t + 1) = N_{2}(t) + P_{1}(t) \cdot N_{2}(t) + P_{2}(t) \cdot N_{3}(t) - \frac{N_{2}(t)}{T_{1}(t)}$$ $$N_{3}(t + 1) = N_{3}(t) + \frac{N_{2}(t)}{T_{1}(t)} - P_{3}(t) \cdot \frac{N_{3}(t)}{T_{2}(t)} - (1 - P_{3}(t)) \cdot \frac{N_{3}(t)}{T_{2}(t)}$$ $$N_{4}(t + 1) = N_{4}(t) + P_{3}(t) \cdot \frac{N_{3}(t)}{T_{2}(t)}$$ $$N_{5}(t + 1) = N_{5}(t) + (1 - P_{3}(t)) \cdot \frac{N_{3}(t)}{T_{2}(t)}$$Notice that, *P* ~1~(*t*)·*N* ~2~(*t*) is the number of new SARS cases among the general public caused by *N* ~2~(*t*); and *P* ~2~(*t*)·*N* ~3~(*t*) is the number of new SARS cases among front-line hospital staff caused by *N* ~3~(*t*). We assume the *T* ~1~(*t*) of *N* ~2n~(*t*) and *N* ~2d~(*t*) is same, then:$$N_{2\text{n}}(t + 1) = N_{2\text{n}}(t) + P_{1}(t) \cdot N_{2}(t) - \frac{N_{2\text{n}}(t)}{T_{1}(t)}$$ $$N_{2\text{d}}(t + 1) = N_{2\text{d}}(t) + P_{2}(t) \cdot N_{3}(t) - \frac{N_{2\text{d}}(t)}{T_{1}(t)}$$The time step in our models is set as one day.

3. Theoretical analysis
=======================

First, let us assume that the growth pattern of total cumulative SARS cases is linear against time *t*, and let *N* ~s~(*t*) be total cumulative SARS cases at time *t*, then:$$\begin{array}{l}
{N_{\text{s}}(t) = b_{0} + b_{1} \cdot t} \\
{N_{\text{s}}(t + 1) = b_{0} + b_{1} \cdot (t + 1)} \\
\end{array}$$Here, *b* ~0~, *b* ~1~ are constants.$$N_{\text{s}}(t + 1) - N_{\text{s}}(t) = b_{1}$$ *b* ~1~ is the number of new SARS cases at time *t*. That is to say, if *b* ~1~ is constant, the growth pattern of SARS cases is linear against time *t*. From Eq. [(3)](#eq2){ref-type="disp-formula"}, the number of new cases of SARS removed to *N* ~3~(*t*) is *N* ~2~(*t*)/*T* ~1~(*t*), then *N* ~s~(*t*  + 1) −  *N* ~s~(*t*) =  *N* ~2~(*t*)/*T* ~1~(*t*). If *N* ~2~(*t*  + 1) −  *N* ~2~(*t*) = 0, *N* ~s~(*t*  + 1) −  *N* ~s~(*t*) is constant and the growth pattern of SARS cases will be linear; if *N* ~2~(*t*  + 1) −  *N* ~2~(*t*) \> 0 it will be exponential; if *N* ~2~(*t*  + 1) −  *N* ~2~(*t*) \< 0 it will be a power curve. From Eq. [(2)](#eq1){ref-type="disp-formula"}:$$N_{2}(t + 1) - N_{2}(t) = P_{1}(t) \cdot N_{2}(t) + P_{2}(t) \cdot N_{3}(t) - \frac{N_{2}(t)}{T_{1}(t)} = 0$$ $$P_{1}(t) \cdot T_{1}(t) + P_{2}(t) \cdot T_{1}(t) \cdot \frac{N_{3}(t)}{N_{2}(t)} = 1$$For a linear growth pattern *N* ~2~(*t*) has to be stable. To satisfy the Eq. [(8)](#eq5){ref-type="disp-formula"}, *N* ~3~(*t*) also has to be stable: *N* ~3~(*t*  + 1) −  *N* ~3~(*t*) = 0. From Eq. [(3)](#eq2){ref-type="disp-formula"}:$$N_{3}(t + 1) - N_{3}(t) = \frac{N_{2}(t)}{T_{1}(t)} - \frac{N_{3}(t)}{T_{2}(t)}$$

If *N* ~3~(*t*  + 1) −  *N* ~3~(*t*) = 0, *N* ~3~(*t*)/*N* ~2~(*t*) =  *T* ~2~(*t*)/*T* ~1~(*t*). From Eq. [(8)](#eq5){ref-type="disp-formula"}, then$$P_{1}(t) \cdot T_{1}(t) + P_{2}(t) \cdot T_{2}(t) = 1$$Let *R*(*t*) =  *P* ~1~(*t*)·*T* ~1~(*t*) +  *P* ~2~(*t*)·*T* ~2~(*t*), the outbreak pattern of SARS cases is determined by the following conditions: *R*(*t*) = 1, linear growth; *R*(*t*) \> 1, exponential growth; *R*(*t*) \< 1, power growth. If *P* ~2~(*t*) = 0, i.e. SARS infection among front-line hospital staff is completely controlled, then the Eq. [(9)](#eq6){ref-type="disp-formula"} is written as: *R*(*t*) =  *P* ~1~(*t*)·*T* ~1~(*t*) = 1. Through qualitative analysis, we conclude that the outbreak pattern of SARS cases is determined by four parameters: the infection rate among the general public *P* ~1~(*t*) and front-line hospital staff *P* ~2~(*t*), the infectious period of non-hospitalized patients *T* ~1~(*t*) and the treatment period of SARS patients in hospital *T* ~2~(*t*).

4. Model parameter estimation
=============================

The data provided by the CMH include total cumulative SARS cases, cumulative SARS cases among front-line hospital staff, cumulative SARS mortality, cumulative cured SARS cases, and cumulative suspected SARS cases on the Chinese Mainland ([Table 1](#tbl1){ref-type="table"} ). Let us define:*N* ~s~(*t*) is total cumulative SARS cases at time *t*;*N* ~d~(*t*), cumulative SARS cases among front-line hospital staff at time *t*;*N* ~n~(*t*), cumulative SARS cases among general public at time *t*;*N* ~5~(*t*) is cumulative SARS mortality at time *t*;*N* ~4~(*t*) is cumulative cured SARS cases at time *t*.Then:$$N_{3}(t) = N_{\text{s}}(t) - N_{4}(t) - N_{5}(t)$$ $$N_{2}(t) = T_{1}(t) \cdot \lbrack N_{\text{s}}(t + 1) - N_{\text{s}}(t)\rbrack$$ $$N_{\text{n}}(t) = N_{\text{s}}(t) - N_{\text{d}}(t)$$ $$N_{2\text{n}}(t) = T_{1}(t) \cdot \lbrack N_{\text{n}}(t + 1) - N_{\text{n}}(t)\rbrack$$ $$N_{2\text{d}}(t) = T_{1}(t) \cdot \lbrack N_{\text{d}}(t + 1) - N_{\text{d}}(t)\rbrack$$From Eqs. [(6)](#eq3){ref-type="disp-formula"} and [(13)](#eq7){ref-type="disp-formula"}:$$P_{1}(t) = \frac{\left\{ T1(t) \cdot \lbrack N_{\text{n}}(t + 2) - N_{\text{n}}(t + 1)\rbrack - T_{1}(t) \cdot \lbrack N_{\text{n}}(t + 1) - N_{\text{n}}(t)\rbrack + \lbrack N_{\text{n}}(t + 1) - N_{\text{n}}(t)\rbrack \right\}}{N_{2}(t)}$$From Eqs. [(7)](#eq4){ref-type="disp-formula"} and [(14)](#eq8){ref-type="disp-formula"}:$$P_{2}(t) = \frac{\left\{ T_{1}(t) \cdot \lbrack N_{\text{d}}(t + 2) - N_{\text{d}}(t + 1)\rbrack - T_{1}(t) \cdot \lbrack N_{\text{d}}(t + 1) - N_{\text{d}}(t)\rbrack + \lbrack N_{\text{d}}(t + 1) - N_{\text{d}}(t)\rbrack \right\}}{N_{3}(t)}$$The weekly average values of *P* ~1~(*t*), *P* ~2~(*t*) last week at time *t* are calculated as:$$P_{1\_\text{w}}(t) = \frac{\sum\left\{ T_{1}(t) \cdot \lbrack N_{\text{n}}(t + 2) - N_{\text{n}}(t + 1)\rbrack - T_{1}(t) \cdot \lbrack N_{\text{n}}(t + 1) - N_{\text{n}}(t)\rbrack + \lbrack N_{\text{n}}(t + 1) - N_{\text{n}}(t)\rbrack \right\}}{\sum{N_{2}(t)}}$$ $$P_{2\_\text{w}}(t) = \frac{\sum\left\{ T_{1}(t) \cdot \lbrack N_{\text{d}}(t + 2) - N_{\text{d}}(t + 1)\rbrack - T_{1}(t) \cdot \lbrack N_{\text{d}}(t + 1) - N_{\text{d}}(t)\rbrack + \lbrack N_{\text{d}}(t + 1) - N_{\text{d}}(t)\rbrack \right\}}{\sum{N_{3}(t)}}$$The standard errors were estimated by following [@bib16]. Let *p* ~1~  =  *P* ~1_w~(*t*); *q* ~1~  = 1 −  *p* ~1~; $n_{1} = \sum{N_{2}(t)}$; *p* ~2~  =  *P* ~2_w~(*t*); *q* ~2~  = 1 −  *p* ~2~; $n_{2} = \sum{N_{2}(t)}$; *S* ~1~, *S* ~2~ and *S* are standard errors of *P* ~1_w~(*t*), *P* ~2_w~(*t*) and *R*(*t*), then:$$\begin{array}{l}
{S_{1} = \sqrt{\frac{p_{1} \cdot q_{1}}{n_{1}}}} \\
{S_{2} = \sqrt{\frac{p_{2} \cdot q_{2}}{n_{2}}}} \\
{S = \sqrt{T_{1} \cdot S_{1}^{2} + T_{2} \cdot S_{2}^{2}}} \\
\end{array}$$It is obvious that using the rolling weekly averages of infection rates reduces estimation errors since the higher the $\sum{N_{2}(t)}\,\text{or}\,\sum{N_{3}(t)}$, the lower the standard errors.Table 1The cumulative SARS cases in Mainland China from April 21 to May 12, 2003, released by the Chinese Ministry of HealthDateDaysTotalDeadCuredDoctors[a](#tbl1fn1){ref-type="table-fn"}April 2112158971213480April 22223051061231517April 23324221101254541April 24426011151277578April 26627531221285588April 27729141311299610April 28831061391306653April 29933031481322709April 301034601591332727May 11136381811351753May 21237993221372778May 31339711901406810May 41441251971416832May 51542802061433851May 61644092141460883May 71745602191487901May 81846982241529917May 91948052301582925May 102048842351620931May 112149482401652935May 122250132521693941[^1][^2]

Clinical observations indicate that in mainland of China, the infectious period of the non-hospitalized persons is usually between 4 and 5 days with an average of 4.5 days ([@bib29]). The average treatment period (admission to discharge) of hospitalized SARS patients is 14 days. About 95% of patients are completely cured. Thus, we assume that the parameters of *T* ~1~(*t*), *T* ~2~(*t*) and *P* ~3~(*t*) are constant, and let *T* ~1~  = 4.5, *T* ~2~  = 14, *P* ~3~  = 0.95. The model parameters *P* ~1_w~(*t*), *P* ~2_w~(*t*), *R*(*t*), and their standard errors are shown in [Table 2](#tbl2){ref-type="table"} .Table 2Estimated values of *P*~1_w~(*t*), *P*~2_w~(*t*), *R*(*t*) and their standard errors *S*~1~, *S*~2~ and *S*DateDay*N*~s~*r*$\sum{N_{3}(t)}$*P*~2_w~(*t*)*S*~2~$\sum{N_{2}(t)}$*P*~1_w~(*t*)*S*~1~*R*(*t*)*S*April 21121580.0659April 22223050.0495April 23324220.0713April 24426010.0568April 26627530.0568April 27729140.063868410.03780.002342660.21440.00631.49370.0159April 28831060.061585020.01690.00145152.50.20310.0061.15030.0130April 29933030.046495050.02300.00155197.50.23290.00591.37060.0137April 301034600.0502105060.01500.001254720.17860.00521.0140.0118May 11136380.0433115650.02590.001553910.18350.00531.18750.0125May 21237990.0443124610.01780.001254810.17600.00511.04130.0118May 31339710.0381134900.00850.00085449.50.17080.00510.88670.0112May 41441250.0369145720.00620.000752830.14730.00490.74920.0106May 51542800.0297155520.01120.000849770.18180.00550.97490.0120May 61644090.0337164540.00780.000749500.15980.00520.82890.0113May 71745600.0298173390.00510.000547700.15290.00520.75890.0112May 81846980.0225181670.00170.000345270.12320.00490.57730.0104May 91948050.0163190550.00210.00034108.50.11390.00500.5420.0106May 102048840.0130197090.00230.00033703.50.10090.00500.48540.0106May 112149480.013120253−0.002--3298.50.16080.00640.6895--May 122250130.0145206800.00003.4E−053046.50.05520.00410.24850.0088[^3]

The instantaneous rate of increase in cumulative SARS cases *N* ~s~(*t*) is defined as: *r*  = ln\[*N* ~s~(*t*  + 1)/*N* ~s~(*t*)\]. If the instantaneous rate of increase is negative and linear correlated with cumulative SARS cases, the growth pattern of cumulative SARS cases is a logistic ([@bib31]).

5. Results
==========

[Fig. 1](#fig1){ref-type="fig"}b illustrates how effective reproductive number *R* determines the outbreak pattern of SARS cases. The initial values of *N* ~1~(0), *N* ~2~(0), *N* ~3~(0), *N* ~4~(0), *N* ~5~(0) are from the data of April 21, 2003, released by CMH. Changing the values *P* ~1~, *P* ~2~, *P* ~3~, *T* ~1~ and *T* ~2~ produce different curves for the total number of cumulative cases. The simulation results further support the conclusion that *R* is the threshold for the outbreak pattern of SARS.

Sensitivity analysis indicates that *T* ~1~ and *P* ~1~ are the most sensitive parameters, *T* ~2~ and *P* ~2~ are less sensitive and *P* ~3~ is the least sensitive ([Fig. 2](#fig2){ref-type="fig"} ). Therefore, *R* is mainly determined by *P* ~1~, *P* ~2~, *T* ~1~ and *T* ~2~.Fig. 2Sensitivity analysis of model parameters *P*~1~, *P*~2~, *P*~3~, *T*~1~, *T*~2~. Each parameter was increased or reduced by 20% while the other parameters remained unchanged. The linear curve is the contrasting curve (C) (*R* = 1, *P*~1~ = 0.01404, *P*~2~ = 0.1785, *T*~1~ = 4.5, *T*~2~ = 14). The initial values of total cumulative cases, cumulative mortality, cumulative recovered patients and cumulative cases are 3106, 139, 1306 and 653, respectively. The curves of *P*~3~\* 1.2 and *P*~3~\* 0.8 are totally overlapped with the contrasting curve (C).

[Fig. 3](#fig3){ref-type="fig"}a shows that the effective reproductive number (*R*) and infection rates (*P* ~1~, *P* ~2~) among front-line hospital staff and the general public are significantly negatively correlated with total cumulative SARS cases (*N* ~s~). The instantaneous rate of increase in total cumulative cases is also significantly negatively correlated with the number of total cumulative cases, indicating that the outbreak pattern of cumulative SARS cases in China is a logistic growth curve. [Table 3](#tbl3){ref-type="table"} shows the results of linear regression between dependents variables (*R*, *P* ~2~, *P* ~1~, *r*) and independent variable (*N* ~s~). From [Table 3](#tbl3){ref-type="table"}, the maximum *R* (equal basic reproductive number *R* ~0~), *P* ~2~, *P* ~1~, *r* (equal *b* ~0~ in [Table 3](#tbl3){ref-type="table"}) are 2.8716, 0.0684, 0.4245 and 0.1129 when the cumulative SARS case (*N* ~s~) is approaching zero. Therefore, in the early stage of SARS outbreak, each SARS infect 1.9 (*P* ~1~·*T* ~1~  = 0.4245 × 4.5) members of the general public, 0.9576 (*P* ~2~·*T* ~2~  = 0.0684 × 14) front-line hospital staff. During the study period, we estimate that each infected individual infects 0.48--1.49 individuals, average 0.93 (0.18 front-line hospital staff and 0.75 members of the general public) during the study period of 3 weeks. In general, the infection of SARS person to front-line hospital staff is better managed due to the improved protection measures taken in hospitals.Fig. 3(a) The negative relationship between the SARS infection rate among the general public (*P*~1~, ▴) (*R*^2^ = 0.743, *p* = 0.000), the infection rate among front-line hospital staff (*P*~2~, +) (*R*^2^ = 0.740, *p* = 0.000), the effective reproductive number (*R*, ×) (*R*^2^ = 0.813, *p* = 0.000), the relative rate of increase of total cumulative cases (*r*, ●) (*R*^2^ = 0.934, *p* = 0.000) against total cumulative cases of SARS in China. (b) The simulated total cumulative SARS cases (*N*~s~ − *S*, +), observed values of the total cumulative SARS cases (*N*~s~ − *O*, ■), the simulated cumulative SARS cases among front-line hospital staff (*N*~d~ − *S*, ×), the observed cumulative SARS cases among front-line hospital staff (*N*~d~ − *O*, ▴), the simulated cumulative SARS cases among the general public (*N*~n~ − *S*, \*) and the observed cumulative SARS cases among the general public (*N*~d~ − *O*, ●) in China from April 21 to May 12, 2003.Table 3Linear regressions between dependents (*R*, *P*~2~, *P*~1~, *r*) and independent *N*~s~ by using linear models: *r* = *b*~0~ + *b*~1~*N*~s~, *R* = *b*~0~ + *b*~1~*N*~s~, *P*~2~ = *b*~0~ + *b*~1~*N*~s~, *P*~1~ = *b*~0~ + *b*~1~*N*~s~DependentMth*R*^2^d.f.*F*Sigf*b*~0~*b*~1~*R*LIN0.87516111.800.0002.8716−0.0005*P*~2~LIN0.8331679.570.0000.0684−0.00001*P*~1~LIN0.7451646.830.0000.4245−0.00007*r*LIN0.90922218.510.0000.11290.00002

[Fig. 3](#fig3){ref-type="fig"}b shows the simulated and observed values of total cumulative cases, cumulative cases among front-line hospital staff and the general public. The negative relationship between infection rates and cumulative cases has been incorporated into the model. In general, the simulation curves are a good fit to the observed growth patterns, but the discrepancy between observed and expected became a little larger over the last week. Higher accuracy of simulation is achieved if it is conducted within a 1-week time frame ([Fig. 4](#fig4){ref-type="fig"} ). These results indicate that the model is generally a good predictor of the dynamics of SARS epidemic.Fig. 4Simulations conducted within a 1-week time frame with the simulated total cumulative SARS cases (+), the simulated cumulative SARS cases among front-line hospital staff (×), the simulated cumulative SARS cases among the general public (\*); the observed values of the total cumulative SARS cases (■), the observed cumulative SARS cases among front-line hospital staff (▴), and the observed cumulative SARS cases among the general public (●) in China from April 21 to May 12, 2003. (a) First week, (b) Second week and (c) Third week.

6. Discussions
==============

Although there have been no reported cases of transmission of SARS during pre-symptomatic period ([@bib17]), our study suggests that such transmission by SARS person before hospitalized is quite high; about 2--4 times higher than transmission from hospitalized patients. At present, the transmission process by non-hospitalized persons is not completely understood. Infection paths of nearly 20--30% SARS patients are not clear in mainland of China. Though it is generally believed SARS persons are only infectious during the few days with symptoms, alternative infection paths may exist. According to a survey in China, the SARS virus can survive several days outside the body of SARS persons. It is possible these viruses explain the high proportion of SARS cases without unknown origins.

We estimate that the basic reproductive number *R* ~0~ for a single infected individual in the early stage is 2.8716, which is very close to the estimation of *R* ~0~ in Singapore and Hong Kong by [@bib17] and [@bib24]. The rate of SARS transmission is not very high compared to some airborne diseases, which suggests that transmission of the SARS virus requires a relatively long-term period of close contact. This is supported by the fact that SARS cases most often occur among family members, residents or workers in the same apartment complex or office building and front-line hospital staff.

Some epidemiologists have suggested that the apparently linear growth in SARS cases is due to the slow rate of transmission of the virus, and estimate that each infected individual infects no more than two other people ([@bib26]). Our study generally supports this speculation, but indicates that the outbreak pattern of the accumulative SARS cases in China is logistic in general, rather than linear. The infection rates, effective reproductive number and the instantaneous rate of increase in total cumulative cases are significantly negatively correlated with the total number of cumulative cases. This is a good indication that the SARS epidemic can be well managed by using traditional prevention measures like isolation, reduction of contacts, etc.

The basic and effective reproductive numbers are good indicators of the severity of epidemic diseases and effectiveness of control ([@bib13]). In general, estimation of these parameters from disease outbreak data is not easy since the actual process of infection is not observed, data are often incomplete and the rate of infection is often non-linear. [@bib15] accurately simulated the growth of an HIV infected population. Some other methods are also proposed to estimate model parameters, like the Martingale method ([@bib10], [@bib30], [@bib5], [@bib4], [@bib12], [@bib6]), Markov Chain Monte Carlo method ([@bib23]). The SARS model described here is a variant of the SIR model with the addition of two-stage infections and two sub-compartments that reflect unique features of the SARS virus. The model has the advantage that its parameters are easy to estimate from the data released by the CHM. The advantage of our estimation is that *R* ~0~, *R*, *P* ~1~, *P* ~2~ can be estimated by using simple data of cumulative SARS cases as shown in [Table 1](#tbl1){ref-type="table"}.

Our model also includes three basic components: susceptible (*N* ~1~), infectious (*N* ~2~, *N* ~3~) and removals (*N* ~4~, *N* ~5~). Thus, it is basically a SIR model used widely in epidemiological studies (e.g. [@bib7], [@bib20], [@bib14], [@bib3], [@bib11], [@bib9], [@bib17], [@bib24]). The difference of our model from the classic SIR model is that we further divide the infectious component into two parts: hospitalized and non-hospitalized populations, and we divide the removal component into two parts: cured and dead populations. These modifications were specially done for SARS transmissions. The other difference is that we define the infectious rate differently. Let *S*(*t*) is the number of susceptible population at time *t*, *I*(*t*) is the number of infectious population at time *t*, *α* is the maximum infection rate, *τ* is the incubation time. In the classic SIR model (e.g. [@bib21], [@bib22]), the contribution of *I*(*t*) to the increase of newly infection population is calculated as: *Δ*  =  *α*·*S*(*t*)·*I*(*t*  −  *τ*). In our model, we define *P*(*t*) as the infection rate of infectious individual of *I*(*t*) at time *t*. Thus, we have the following equation: *Δ*  =  *P*(*t*)·*I*(*t*). The parameter *P*(*t*) varies in time. It contains the combined effect of incubation time, immunity and control efforts. In the classic SIR model, *α* is assumed to be constant, only *S*(*t*) and *I*(*t*  −  *τ*) determine the increase of newly infected population. In fact, isolation measures by human obviously affect the infection rate *α*. Such an effect is not well presented in the classic SIR model.

It is obvious that our model has advantages over the conventional SIR model because it has fewer parameters. This will make parameter estimation easier without knowing detailed mechanism of disease transmission (e.g. incubation time, immunity and control efforts) and the susceptible population size. Although the parameters of *P* ~1~(*t*), *P* ~2~(*t*), *T* ~1~(*t*), *T* ~2~(*t*) vary in time, it is reasonable to assume they are stable when they are estimated at the rolling interval of 1 week.

Using our model, the infection rate of one infectious individual can easily be estimated at any time if the accumulative numbers of infection and dead cases are given. Though this epidemiological model and the parameter estimation method are specially designed for SARS transmission, they are also applicable to other infectious diseases, and to population growth of other organisms.

The decline of the effective reproductive number indicates that the measures adopted to control SARS in China are effective. One of the key preventative measures in China is the complete isolation of those confirmed or suspected of having been infected, including anyone likely to have had close contact with confirmed or suspected SARS carriers. This measure is strongly recommended because the model shows that both the infectious period (*T* ~1~) and the infection rate (*P* ~1~) are very sensitive parameters. In addition to isolating confirmed cases reducing the infectious period (*T* ~1~) is an effective means of reducing SARS infection. This requires the early identification of infected individuals using modern diagnostic techniques.
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[^1]: *Source*: Chinese Ministry of Health.

[^2]: Includes all front-line hospital staff.

[^3]: *N*~s~ is the total cumulative SARS cases. *r* is the instantaneous increase rate. "--" *S*~2~ and *S* are not calculated due to the negative value of *P*~2~(*t*).
